Market Overview

Aviragen Therapeutics Reports Q4 EPS $(0.15) vs $(0.19) Est., Sales $100K vs $600K In Same Qtr. Last Year

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Earnings

 

Related Articles (AVIR)

Loading...